LUMICKS: Cancer Cell Paper Identifies Avidity Enhancement As New Strategy for Improving CAR T Therapy for Acute Myeloid Leukemia
Research Revealed Through Cell Avidity Measurement Demonstrates Superior Tumor Clearance In Vivo Due To "Avidity Enhancement" AMSTERDAM, May 24, 2022 /PRNewswire/ -- LUMICKS, a leading